When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VIVO - Meridian resubmits EUA application for Revogene SARS-CoV-2 molecular assay
Meridian Bioscience Inc.
Meridian Bioscience ([[VIVO]] +0.8%) has re-submitted its application for Emergency Use Authorization ((EUA)) to the U.S. FDA for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene platform.Shares up more than 12% YTD.The company had voluntarily withdrew its EUA application in order to conduct additional studies based on guidance from the FDA, in February.